ArticleIndian journal of pediatrics2025
Insulin Like Growth Factor-1 as a Screening Tool to Differentiate Between Idiopathic Short Stature and Growth Hormone Deficiency.
Article in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Measurement of serum insulin-like growth factor-1 (IGF-1) is a useful screening test for growth hormone deficiency (GHD) because unlike growth hormone, it has minimal circadian variation. In this retrospective study, the authors compared IGF-1 concentrations in children with GHD vs. idiopathic short stature (ISS) to define IGF-1 cut-off to differentiate the two. Of the 75 children studied, 38 were GHD and 37 ISS. Weight, height, BMI Z-scores, bone age: age ratio, IGF-1 concentrations and IGF-1 Z-scores were significantly lower in the GHD group. The best IGF-1 Z-score cut-off was -2.41 (sensitivity: 74.3% and specificity: 89.2%). Many children who are non-GH deficient fail growth hormone stimulation tests and get wrongly diagnosed as GHD and receive a lesser dose of GH leading to suboptimal response. In such patients, if the IGF-1 is well above the cut-off (-2.41), other diagnostic possibilities including ISS may be considered for GH dose adjustment.
Indexed as
Identifiers
40719978What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.